Completed

Physical Activity and Cardiovascular Risk in Breast Cancer Survivors

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Behavior+6

+ Breast Diseases

+ Breast Neoplasms

From 40 to 80 Years
See all eligibility criteria
How is the trial designed

Other

Utilizing specific methods not covered by standard models in order to address unique research questions.
Observational
Study Start: July 2024
See protocol details

Summary

Principal SponsorHacettepe University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: July 30, 2024

Actual date on which the first participant was enrolled.

This study explores the connection between physical activity levels and cardiovascular health in breast cancer survivors. Cardiovascular disease (CVD) is a major cause of illness and death globally, and it increasingly affects individuals after surviving breast cancer, especially as they age. Regular physical activity is known to lower many risk factors for CVD, such as high blood pressure and stress, and improve overall health. For breast cancer survivors, engaging in physical activity during and after treatment can enhance survival rates and quality of life. However, there is limited evidence on how physical activity impacts long-term cardiovascular outcomes in these individuals. This study aims to find the best types of physical activities and assess how different activity levels affect cardiovascular risks in various age groups of breast cancer survivors. Participants in this study will have their physical activity levels measured using the SenseWear Armband, a device worn for at least seven days to track movement and energy expenditure. The study will gather detailed demographic information such as age, medical history, and lifestyle habits, and assess participants' cardiovascular risk using the SCORE2 system. This system evaluates risk based on factors like cholesterol levels and blood pressure. Additionally, the study will measure participants' exercise capacity through a six-minute walking test and evaluate their quality of life and anxiety levels using standardized questionnaires. By analyzing these factors, the study aims to better understand the role of physical activity in managing cardiovascular health in breast cancer survivors, potentially leading to improved health outcomes.

Official TitleThe True Face of the Pyramid; Physical Activity Level and Cardiovascular Risk in Patients With Breast Cancer
NCT06837701
Principal SponsorHacettepe University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

70 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Other

Some studies use unique or mixed approaches that don't fit standard categories. These may include innovative observational methods or studies tailored to specific research questions.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Female

Biological sex of participants that are eligible to enroll.

From 40 to 80 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

BehaviorBreast DiseasesBreast NeoplasmsCardiovascular DiseasesMotor ActivityNeoplasmsNeoplasms by SiteSkin DiseasesSkin and Connective Tissue Diseases

Criteria

Inclusion Criteria: 1. To be between the ages of 40-80 years, 2. Volunteering to participate in the research, 3. At least 15 months after breast cancer surgery, 4. 6 months after active breast cancer treatment (ie surgery/chemotherapy) 5. Having no problem in reading and/or understanding the scales and being able to cooperate with the tests. Exclusion Criteria: 1. Presence of active infection, 2. Having a neurological disease or other clinical diagnosis that may affect cognitive status, 3. Having musculoskeletal and neurological disease, symptomatic heart disease, previous lung surgery and malignant disease that may affect exercise performance. 4. Presence of unstable hypertension or diabetes mellitus

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Hacettepe University

Ankara, Turkey (Türkiye)Open Hacettepe University in Google Maps
CompletedOne Study Center